Directory

Deborah joined the Duke Clinical and Translational Science Institute in March 2022 as the Chief Administrative Officer and Assistant Dean for Translational Science. She brings her knowledge, expertise, and management skills to help lead the Duke CTSI team into the next phase of growth and prosperity.

Ms. Kingsbury came to Duke CTSI in July 2014 with a Bachelor of Science degree in human services and psychology from Wingate University. Her previous role was with a healthcare system, where she worked in research specializing in traumatic brain injury. Ms. Kingsbury enjoys working in research because it allows her to meet people in the community and see how the contribution of each individual serves a larger purpose to benefit the community as a whole.

Professor of Pediatrics

The focus of our research has been the development of gene therapy with  adeno-associated virus (AAV) vectors, most recently by genome editing with CRISPR/Cas9. We have developed gene therapy for inherited disorders of metabolism, especially glycogen storage disease (GSD) and phenylketonuria (PKU). 

Dr. Lam provides programmatic, administrative, and operational leadership for the Child Health Core, and coordinates and supports efforts to achieve the goals and aims of the CTSA grant. She serves as a liaison with Duke investigators and staff involved in child health research, as well as other CTSI components and national CTSA consortium workgroups. Dr. Lam is also responsible for facilitating the development and implementation of new proposals and initiatives to support child health clinical and translational research.

Mr. Lewis first joined CTSI in 2013 as an intern while earning his degree in Recombinant DNA Technologies and Bioengineering. He became a full-time clinical trials assistant in March 2014.

He currently serves as a Senior Clinical Research Specialist with effort on several studies, including the MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study; a partnership with the N.C. Department of Health and Human Services to understand COVID-19 prevalence and immunity in the community and to monitor the disease over time.

• Pediatric hypertension and hyperlipidemia
• Clinical trials in children with heart disease
• Thrombosis in patients with congenital heart disease
• Enzyme replacement in Pompe disease
• Infective endocarditis

Wan Lan Liang, RN, BSN, MSN, CCRC joined the CTSI in November 2022 as a Research Practice Manager (RPM) for the CTSI Clinical Research Unit. Wan Lan is based in the Duke Early Phase Research Unit (DEPRU).

Sierra Lindo serves as a Project Planner for Duke CTSI where she helps lead the strategic project management, development, and execution of innovative AI Health initiatives, ensuring successful delivery and stakeholder satisfaction to enhance research outcomes.

Chris Lindsell, PhD, professor of Biostatistics & Bioinformatics at Duke, leads the visionary strategic planning, development, and execution of state-of-the-art research for the CTSI and the Duke Clinical Research Institute to achieve its scientific goals.

Mr. Liu is a software developer who grew up in China and moved to the Triangle area in 1997. He received a Bachelor of Science in Computer Science from Hua-zhong University of Science and Technology, Wuhan, China, and has a master’s degree in accounting. He came to the Duke Kannapolis team from the Duke Department of Psychiatry, where he worked over 15 years and contributed to the development of an Electronic Health Record (EHR) software focusing on mental health.